The role of reductive enzymes in cancer cell resistance to mitomycin C
- 30 June 2000
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 3 (3) , 143-148
- https://doi.org/10.1054/drup.2000.0140
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mitomycin resistance in mammalian cells expressing the bacterial mitomycin C resistance protein MCRAProceedings of the National Academy of Sciences, 1999
- Binding of nuclear proteins associated with mammalian DNA repair to the mitomycin C-DNA interstrand crosslinkEnvironmental and Molecular Mutagenesis, 1998
- Pharmacological determinants of the antitumour activity of mitomycin CBiochemical Pharmacology, 1998
- Immunological Quantitation of DT‐Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers: Advanced Tumors Express Greater Levels of DT‐DiaphoraseJapanese Journal of Cancer Research, 1998
- The Intracellular Location of NADH:Cytochromeb5 Reductase Modulates the Cytotoxicity of the Mitomycins to Chinese Hamster Ovary CellsPublished by Elsevier ,1998
- Mitomycin C−DNA Adducts Generated by DT-Diaphorase. Revised Mechanism of the Enzymatic Reductive Activation of Mitomycin CBiochemistry, 1997
- 2,7-Diaminomitosene, a Monofunctional Mitomycin C Derivative, Alkylates DNA in the Major Groove. Structure and Base-Sequence Specificity of the DNA Adduct and Mechanism of the AlkylationJournal of the American Chemical Society, 1996
- Re-evaluation of the molecular pharmacology of mitomycin CEuropean Journal Of Cancer, 1995
- Preferential effects of the chemotherapeutic DNA crosslinking agent mitomycin C on inducible gene expression in vivoEnvironmental and Molecular Mutagenesis, 1995
- DT-diaphorase in activation and detoxification of quinonesCancer and Metastasis Reviews, 1993